<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03200353</url>
  </required_header>
  <id_info>
    <org_study_id>NATROX</org_study_id>
    <nct_id>NCT03200353</nct_id>
  </id_info>
  <brief_title>Evaluation of Sores Treatment by Oxygenotherapy</brief_title>
  <official_title>Evaluation of Sores Treatment by Oxygenotherapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Groupe Hospitalier Paris Saint Joseph</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Groupe Hospitalier Paris Saint Joseph</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patient with chronic wounds are selected to receive NATROX system ; it's a continous
      diffusion of oxygen therapy delivery system. This one is put on the wound during a
      consultation at the hospital and will be followed in home medical care. Every 2 days a nurse
      renew the application at home and patient recharge the system with oxygen every day.

      The complete treatment is prescribe for 4 weeks and at the end patient comes to hospital to
      have a consultation with the doctor.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">April 10, 2017</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Actual">January 10, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>number of patients received the entire treatment (3 to 4 weeks of oxygenotherapy) in home medical care</measure>
    <time_frame>4 weeks</time_frame>
    <description>Patients who have received the entire treatment.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>percentage of patients who can receive skin graft after the therapy</measure>
    <time_frame>1-2 month</time_frame>
    <description>patient eligible to skin graft after the therapy indicate the success of the NATROX system</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>percentage of patient who stopper the treatment</measure>
    <time_frame>4 weeks</time_frame>
    <description>number of patients who have to stop the treatment because of non tolerability among all included patient</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">31</enrollment>
  <condition>Ulcer Venous</condition>
  <arm_group>
    <arm_group_label>Active</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Each patient included receive the experimental device system NATROX during 3 to 4 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>system NATROX (device name)</intervention_name>
    <description>system NATROX (device name) application on the wounds of lower limbs</description>
    <arm_group_label>Active</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age &gt; 18 years

          -  accepted to participate

          -  Patients followed in vascular medicine and entrusted to the home medical care for the
             bandages of chronic wounds with apathetic ulcers, not presenting of granulation tissue
             on their surface

        Exclusion Criteria:

          -  infected ulcers

          -  necrosed ulcers

          -  Arterial ulcers requiring a revascularisation.

          -  Ulcers whose surface is superior in 10x10 cm.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Isabelle P LAZARETH, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Groupe Hospitalier Paris Saint Joseph</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Groupe Hospitalier Paris Saint Joseph</name>
      <address>
        <city>Paris</city>
        <state>Ile-de-France</state>
        <zip>75014</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>June 23, 2017</study_first_submitted>
  <study_first_submitted_qc>June 26, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 27, 2017</study_first_posted>
  <last_update_submitted>June 17, 2020</last_update_submitted>
  <last_update_submitted_qc>June 17, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 18, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Varicose Ulcer</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

